Spots Global Cancer Trial Database for hematopoietic stem cell transplant
Every month we try and update this database with for hematopoietic stem cell transplant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation | NCT03475212 | Cytomegalovirus... Adenovirus Infe... EBV Infection | Virus Specific ... | - | Children's Hospital Los Angeles | |
| Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) | NCT01998633 | Hemophagocytic ... Chronic Active ... Chronic Granulo... HIGM-1 Leukocyte Adhes... IPEX | Hematopoietic S... | 4 Months - 45 Years | Medical College of Wisconsin | |
| Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis | NCT04217356 | Myelofibrosis High-Risk Cance... Bone Marrow Can... | Hematopoietic s... Ruxolitinib Hydroxyurea | 18 Years - 70 Years | University Health Network, Toronto | |
| Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia | NCT00186875 | Acute Lymphobla... Lymphoma, Lymph... | Etoposide, cyta... methotrexate, t... mitoxantrone, c... L-asparaginase,... chemotherapy, i... Hematopoietic S... Natural Killer ... | - 21 Years | St. Jude Children's Research Hospital | |
| Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant | NCT03413800 | Relapsed Hemato... Multiple Myelom... | Lenalidomide-De... | 18 Years - 65 Years | Ciusss de L'Est de l'Île de Montréal | |
| Influenza Vaccine Post Allogeneic Transplant | NCT01215981 | Hematopoietic S... Hematologic Mal... | Influenza vacci... Influenza vacci... | 6 Months - | Masonic Cancer Center, University of Minnesota | |
| Precision Exercise in Children With Malignant Hemopathies | NCT04090268 | Leukemia, Myelo... Leukemia, B-cel... Leukemia, T Cel... Lymphoma, Hodgk... Lymphoma, Non-H... Drepanocytosis Thalassemia Maj... Adrenoleukodyst... | Sport Therapy | 2 Years - 18 Years | University of Milano Bicocca | |
| A Long-term Follow-up Study of Patients Who Received VOR33 | NCT05309733 | Leukemia, Myelo... | VOR33 | - | Vor Biopharma | |
| A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors | NCT06153797 | Hematologic Mal... Caregiver | PATH-C | 18 Years - | Brigham and Women's Hospital | |
| A Long-term Follow-up Study of Patients Who Received VOR33 | NCT05309733 | Leukemia, Myelo... | VOR33 | - | Vor Biopharma | |
| Patient Reported Outcomes and Patient Education in Cellular Therapy Patients | NCT04853277 | Stem Cell Trans... CAR T-Cell Tran... CAR T-Cell Ther... Cellular Therap... Hematopoietic S... HSCT Multiple Myelom... Leukemia Lymphoma | Education | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant | NCT04118530 | Hematopoietic S... Atrial Fibrilla... Atrial Flutter | HSCT Patients | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia | NCT00677859 | Hematologic Mal... | MultiStem® MultiStem® | 18 Years - 65 Years | Healios K.K. | |
| Influenza Vaccine Post Allogeneic Transplant | NCT01215981 | Hematopoietic S... Hematologic Mal... | Influenza vacci... Influenza vacci... | 6 Months - | Masonic Cancer Center, University of Minnesota | |
| Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia | NCT00186966 | Acute Myeloid L... | Fludarabine, Cy... Etoposide, Thio... Hematopoietic s... Total body irra... | - 18 Years | Dutch Childhood Oncology Group | |
| Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant | NCT04118530 | Hematopoietic S... Atrial Fibrilla... Atrial Flutter | HSCT Patients | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) | NCT01998633 | Hemophagocytic ... Chronic Active ... Chronic Granulo... HIGM-1 Leukocyte Adhes... IPEX | Hematopoietic S... | 4 Months - 45 Years | Medical College of Wisconsin | |
| High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma | NCT02416206 | Multiple Myelom... | BeEAM | 18 Years - 70 Years | Northside Hospital, Inc. | |
| Proof-of-Concept Trial of a Positive Psychology Intervention for Caregivers of HSCT Patients | NCT05216978 | Caregiver Hematologic Mal... | Positive Psycho... | 18 Years - | Brigham and Women's Hospital | |
| Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant | NCT03886909 | Hematopoietic S... Hematologic Dis... Physical Activi... Prehabilitation | Exercise Prehabilitation... | 18 Years - | Milton S. Hershey Medical Center | |
| Effects of Compassion Training to Patients Undergoing HSCT on Biological and Psychosocial Parameters | NCT03737084 | Hematopoietic S... | CBCT Interventi... | 18 Years - 50 Years | Hospital Israelita Albert Einstein | |
| Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) | NCT00912223 | Lymphoma, Non-H... | Hematopoietic S... | 1 Year - 75 Years | Medical College of Wisconsin | |
| Effects of Compassion Training to Patients Undergoing HSCT on Biological and Psychosocial Parameters | NCT03737084 | Hematopoietic S... | CBCT Interventi... | 18 Years - 50 Years | Hospital Israelita Albert Einstein | |
| Muscle Stimulation for Physical Function During Stem Cell Transplant | NCT04364256 | Autologous Hema... | RS-4i Plus Sequ... | 18 Years - | VA Office of Research and Development | |
| Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies | NCT00886522 | Hematological M... | Intrabone cord ... | 18 Years - 65 Years | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies | NCT00886522 | Hematological M... | Intrabone cord ... | 18 Years - 65 Years | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) | NCT00750737 | Invasive Fungal... Hematologic Mal... | Posaconazole ABLC | 18 Years - | M.D. Anderson Cancer Center | |
| Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia | NCT00677859 | Hematologic Mal... | MultiStem® MultiStem® | 18 Years - 65 Years | Healios K.K. | |
| Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO) | NCT02050347 | Non-Hodgkin's L... B-Cell ALL B-Cell CLL | CD19.CAR-CD28Z ... CD19.CAR-CD28Z ... | - | Baylor College of Medicine | |
| Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia | NCT00186875 | Acute Lymphobla... Lymphoma, Lymph... | Etoposide, cyta... methotrexate, t... mitoxantrone, c... L-asparaginase,... chemotherapy, i... Hematopoietic S... Natural Killer ... | - 21 Years | St. Jude Children's Research Hospital | |
| Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation | NCT02356159 | Myelodysplastic... Hodgkin's Lymph... Non-Hodgkin's L... Acute Leukemia Multiple Myelom... | Rituximab Conditioning ch... TMS FLAG EPOCH-F Hematopoietic s... Palifermin | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing | NCT01416025 | Fungal Infectio... | Prospective TDM... | 12 Years - 100 Years | Johns Hopkins University | |
| Precision Exercise in Children With Malignant Hemopathies | NCT04090268 | Leukemia, Myelo... Leukemia, B-cel... Leukemia, T Cel... Lymphoma, Hodgk... Lymphoma, Non-H... Drepanocytosis Thalassemia Maj... Adrenoleukodyst... | Sport Therapy | 2 Years - 18 Years | University of Milano Bicocca | |
| Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial | NCT00939380 | Childhood Cance... | Behavioral inte... CD-ROM DVD and pamphle... Respite care | 18 Years - | Rutgers, The State University of New Jersey | |
| Chinese Herbal Medicine for Immune Reconstitution Following HSCT in Acute Leukemia Patients | NCT02580071 | Acute Leukemia | Sheng-Yu-Tang | 20 Years - | China Medical University Hospital | |
| A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors | NCT06153797 | Hematologic Mal... Caregiver | PATH-C | 18 Years - | Brigham and Women's Hospital | |
| Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB) | NCT05223699 | Acute Myeloid L... Myelodysplasia | MGTA-117 | 18 Years - 75 Years | Magenta Therapeutics, Inc. | |
| Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome | NCT01809392 | Acute Myelocyti... Myelodysplastic... | decitabine | 18 Years - 55 Years | The First Affiliated Hospital of Soochow University | |
| Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS | NCT04849910 | Leukemia, Myelo... Myelodysplastic... | VOR33 Mylotarg | 18 Years - 70 Years | Vor Biopharma | |
| Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant | NCT05984199 | Leukemia, Myelo... | VCAR33 | 18 Years - | Vor Biopharma | |
| Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant | NCT04167683 | Hematologic Dis... Chronic Myeloid... Acute Myeloid L... Acute Lymphoid ... Myelodysplastic... Non Hodgkin Lym... Stem Cell Trans... Chronic Lymphoc... | No intervention | 18 Years - | Rigshospitalet, Denmark | |
| Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial | NCT00939380 | Childhood Cance... | Behavioral inte... CD-ROM DVD and pamphle... Respite care | 18 Years - | Rutgers, The State University of New Jersey |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
